Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
BMC Med Genomics
.
2022 Jul 8;15(1):155.
doi: 10.1186/s12920-022-01309-6.
Authors
Jun Lu
1
,
Wei Xu
2
,
Jie Qian
1
,
Shuyuan Wang
1
,
Bo Zhang
1
,
Lele Zhang
1
,
Rong Qiao
1
,
Minjuan Hu
1
,
Yiming Zhao
1
,
Xiaodong Zhao
3
,
Baohui Han
4
Affiliations
1
Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 Huaihai West Rd, Shanghai, 200030, China.
2
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 800 Dong Chuan Rd, Shanghai, 200240, China.
3
Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, 800 Dong Chuan Rd, Shanghai, 200240, China. xiaodongzhao@sjtu.edu.cn.
4
Department of Pulmonary Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, 241 Huaihai West Rd, Shanghai, 200030, China. 18930858216@163.com.
PMID:
35804347
PMCID:
PMC9270796
DOI:
10.1186/s12920-022-01309-6
No abstract available
Publication types
Published Erratum